Literature DB >> 18765944

Magnetocardiography-guided management of an unusual case of isoimmune complete atrioventricular block complicated by ventricular tachycardia.

Bibhuti Das1, Bettina F Cuneo, Mark Ovadia, Janette F Strasburger, Christopher Johnsrude, Ronald T Wakai.   

Abstract

A fetus who was diagnosed at 25 weeks of gestation with isoimmune AV block presented at 34 weeks with a precipitous fall in ventricular rate and periods of tachycardia. Magnetocardiography revealed the tachycardia to be ventricular. After delivery, nonsustained ventricular tachycardia continued. The baby then successfully paced, and at higher ventricular rates the tachycardia resolved. Five years later the child has normal ventricular function and is doing well. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18765944      PMCID: PMC2814147          DOI: 10.1159/000151677

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  15 in total

1.  Prenatal diagnosis and in utero treatment of torsades de pointes associated with congenital long QT syndrome.

Authors:  Bettina F Cuneo; Marc Ovadia; Janette F Strasburger; Hui Zhao; Tom Petropulos; Jeffrey Schneider; Ronald T Wakai
Journal:  Am J Cardiol       Date:  2003-06-01       Impact factor: 2.778

2.  Magnetocardiographic rhythm patterns at initiation and termination of fetal supraventricular tachycardia.

Authors:  R T Wakai; J F Strasburger; Z Li; B J Deal; N L Gotteiner
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

3.  The influence of fetoabdominal tissues on fetal ECGs and MCGs.

Authors:  J G Stinstra; M J Peters
Journal:  Arch Physiol Biochem       Date:  2002-07       Impact factor: 4.076

4.  Congenital junctional ectopic tachycardia and congenital complete atrioventricular block: a shared etiology?

Authors:  Anne M Dubin; Bettina F Cuneo; Janette F Strasburger; Ronald T Wakai; George F Van Hare; David N Rosenthal
Journal:  Heart Rhythm       Date:  2005-03       Impact factor: 6.343

5.  Newborn infant with maternal anti-SSA antibody-induced complete heart block accompanying cardiomyopathy.

Authors:  Midori Iida; Noboru Inamura; Makoto Takeuchi
Journal:  Circ J       Date:  2006-01       Impact factor: 2.993

6.  Atrial and ventricular fetal heart rate patterns in isolated congenital complete heart block detected by magnetocardiography.

Authors:  R T Wakai; A C Leuthold; C B Martin
Journal:  Am J Obstet Gynecol       Date:  1998-07       Impact factor: 8.661

Review 7.  Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block.

Authors:  N Costedoat-Chalumeau; S Georgin-Lavialle; Z Amoura; J C Piette
Journal:  Lupus       Date:  2005       Impact factor: 2.911

8.  Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis.

Authors:  Lynne E Nield; Earl D Silverman; Glenn P Taylor; Jeffrey F Smallhorn; J Brendan M Mullen; Norman H Silverman; John P Finley; Yuk M Law; Derek G Human; P Gareth Seaward; Robert M Hamilton; Lisa K Hornberger
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

9.  Electrophysiological characteristics of fetal atrioventricular block.

Authors:  Hui Zhao; Bettina F Cuneo; Janette F Strasburger; James C Huhta; Nina L Gotteiner; Ronald T Wakai
Journal:  J Am Coll Cardiol       Date:  2008-01-01       Impact factor: 24.094

10.  Use of tissue velocity imaging in the diagnosis of fetal cardiac arrhythmias.

Authors:  A J J T Rein; C O'Donnell; T Geva; A Nir; Z Perles; I Hashimoto; X-K Li; D J Sahn
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

View more
  2 in total

1.  Fetal magnetocardiogram waveform characteristics.

Authors:  Sarah A Strand; Janette F Strasburger; Ronald T Wakai
Journal:  Physiol Meas       Date:  2019-03-22       Impact factor: 2.833

Review 2.  Diagnosis and treatment of fetal arrhythmia.

Authors:  Annette Wacker-Gussmann; Janette F Strasburger; Bettina F Cuneo; Ronald T Wakai
Journal:  Am J Perinatol       Date:  2014-05-23       Impact factor: 1.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.